Relationship between the status of cell cycle- and apoptosis-regulatory genes and sensitivity to radio-chemotherapy for malignant astrocytic tumors.
Relationship between the status of cell cycle- and apoptosis-regulatory genes and sensitivity to radio-chemotherapy for malignant astrocytic tumors.
批准号:
10557126
负责人:
SAWAMURA Yutaka
金额:
$8.77万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2000
中文摘要
我们对星形细胞肿瘤中p53基因突变的研究揭示了了解低级别肿瘤如何复发和进展为恶性病变的重要性,因为这极大地缩短了患者的生存时间。在低级别星形细胞肿瘤中,带有TP53突变的细胞克隆性地演变为恶性肿瘤,是一个不利的预后因素。TP53、p16/CDKN2A、p14(ARF)、PTEN抑癌基因的频繁共变表明,开发适用于具有广泛基因改变的肿瘤的治疗方法具有重要意义。为了了解P53的功能状态对抗癌药物和放射治疗敏感性的影响,我们分析了34度和37度温敏突变型P53对依托泊苷、紫杉醇、顺铂和ACNU的反应。在LN382细胞中,恢复34度的P53蛋白功能降低了依托泊苷和紫杉醇的细胞毒性,而顺铂的细胞毒性降低,但ACNU没有。细胞周期分析显示,这种敏感性的降低与加入依托泊苷或紫杉醇后向G2M期的转变受损有关。野生型P53功能诱导的细胞周期停滞可能取消依托泊苷和紫杉醇的细胞毒作用,这两种细胞毒作用依赖于G2M相关的细胞凋亡。另一方面,通过恢复p53功能来表达p21可以通过将细胞阻滞在G1期和G2M期来增加胶质母细胞瘤细胞的放射敏感性。为了研究恶性胶质瘤基因治疗的可行性,我们用15个不同的高级别胶质瘤细胞株检测了腺病毒转导的野生型p53抑癌基因的抗增殖作用,发现CAR的表达是决定腺病毒基因治疗恶性胶质瘤转导效率的关键因素。
英文摘要
Our study on p53 gene mutation in astrocytic tumors disclosed the importance to understand how low grade tumors recur and progress to malignant lesions since this dramatically shortens patient survival. Cells with TP53 mutations in low grade astrocytic tumors evolve clonally to malignancy and are an unfavorable prognostic factor. Frequent co-alterations of TP53, p16/CDKN2A, p14 (ARF), PTEN tumor suppressor genes indicate the importance of developing therapeutic approaches applicable to tumors with a broad range of genetic alterations. In order to understand the influence of the functional status of p53 on the sensitivity to anticancer agents and radiotherapy, we analyzed responses of LN382 cells containing a temperature-sensitive mutant p53 at 34 degrees and 37 degrees to etoposide, paclitaxel, cisplatin, and ACNU.Restoration of p53 protein function in LN382 cells at 34 degrees reduced the cytotoxicity of etoposide and paclitaxel, whereas that of cisplatin, but not of ACNU.Transduction of wild-type p53 in LN382 cells also reduced the sensitivity of the cells to etoposide. Cell cycle analysis revealed that this decrease in sensitivity was associated with an impaired transition to the G2M phase subsequent to the addition of etoposide or paclitaxel. The cell cycle arrest induced by wild-type p53 function may abrogate the cytotoxic effects of etoposide and paclitaxel, which are dependent on G2M-associated apoptosis. On the other hand, p21 expression by restoration of p53 function can increase the radiosensitivity of glioblastoma cells by arresting the cells at G1 and G2M phases. To study the feasibility of gene therapy in malignant gliomas, we examined the antiproliferative effect of the adenovirally transduced wild-type p53 tumor suppressor gene by using 15 different high-grade glioma cell lines and found that CAR expression is a critical determinant of transduction efficiencies in adenovirus-based gene therapy for human malignant gliomas.
期刊论文(40)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Ishii N: "Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines."Brain Pathol. 9. 469-479 (1999)
Ishii N:“人类神经胶质瘤细胞系中 TP53、p16/CDKN2A、p14ARF、PTEN 肿瘤抑制基因的频繁共同改变。”Brain Pathol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ishii N, et al.: "Cells with TP53 mutations in low grade astrocytic tumors evolve clonally to malignancy and are an unfavorable prognostic factor."Oncogene. 18. 5870-5878 (1999)
Ishii N 等人:“低度星形细胞肿瘤中具有 TP53 突变的细胞会克隆性地演变成恶性肿瘤,并且是不利的预后因素。”Oncogene。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ikeda J: "Roles ofp53 in chemotherapy of glioblastoma."Hokkaido J Med Sci. 75. 299-314 (2000)
Ikeda J:“p53 在胶质母细胞瘤化疗中的作用。”Hokkaido J Med Sci。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Asaoka K, et al.: "Dependence of efficient adenoviral gene delivery in malignant glioma cells on the expression levels of the Coxsackievirus and adenovirus receptor."J Neurosurg. 92. 1002-1008 (2000)
Asaoka K 等人:“恶性神经胶质瘤细胞中有效腺病毒基因传递对柯萨奇病毒和腺病毒受体表达水平的依赖性。”J Neurosurg。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
多田光宏: "p53の変異とその機能的影響" 佐谷秀行監修 : p53-癌抑制の分子メカニズムと臨床応用, 秀潤社, 142 (1998)
Mitsuhiro Tada:“P53突变及其功能效应”由Hideyuki Saya监督:p53癌症抑制的分子机制和临床应用,Shujunsha,142(1998)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 15 条
Investigation for oncogenes relating to chemotherapy resistance of human malignant gliomas
-
批准号:14571295
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2002
-
负责人:SAWAMURA Yutaka
-
依托单位:
Establishment of genetic diagnostics of brain tumors : Rapid diagnosis of mutation of p53 tumor suppressor gene.
-
批准号:08457355
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.35万
-
财政年份:1996
-
负责人:SAWAMURA Yutaka
-
依托单位:
Molecular genetic study on the relation of parental alleles to the loss of tumor suppressor genes in gliomas.
-
批准号:04670846
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.28万
-
财政年份:1992
-
负责人:SAWAMURA Yutaka
-
依托单位:
海外基金